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Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta, GeorgiaABSTRACT Many of the molecules that mediate G-protein signaling are thought to constitutively associate with each other in
variably stable signaling complexes. Much of the evidence for signaling complexes has come from Fo¨rster resonance energy
transfer and bioluminescence resonance energy transfer (BRET) studies. However, detection of constitutive protein association
with these methods is hampered by nonspeciﬁc energy transfer that occurs when donor and acceptor molecules are in close
proximity by chance. We show that chemically-induced recruitment of local third-party BRET donors or acceptors reliably sepa-
rates nonspeciﬁc and speciﬁc BRET. We use this method to reexamine the constitutive association of class A G-protein-coupled
receptors (GPCRs) with other GPCRs and with heterotrimeric G-proteins. We ﬁnd that b2 adrenoreceptors constitutively asso-
ciate with each other and with several other class A GPCRs. In contrast, GPCRs and G-proteins are unlikely to exist in stable
constitutive preassembled complexes.INTRODUCTIONMany cellular functions, including signal transduction,
depend on static or dynamic protein-protein association.
Unfortunately, few methods are available to assess protein-
protein interactions in living cells. Among the most useful
are methods based on resonance energy transfer (RET)
between proteins labeled with genetically-encoded fluores-
cent or luminescent molecules. These methods are especially
useful for detecting changes in protein association or con-
formation due to physiological or pharmacological manipu-
lation. However, it is more difficult to use RET techniques
to determine if proteins are constitutively associated because
both random collisional encounters and specific protein
interactions generate RET signals (1). Nonspecific RET due
to random interactions is particularly problematic in live
cells when the labeled proteins are overexpressed or are
confined to a subcellular compartment such as the plasma
membrane. In principle, specific and nonspecific RET can
be distinguished by changing either the donor/acceptor ratio
(saturation RET) or the total concentration of these proteins,
or by introducing an unlabeled competitor (2–4). These
approaches require graded control of protein expression
across a broad range of concentrations (including physiolog-
ical concentrations), accurate measurement of expression
levels, and knowledge of the subcellular location of the
expressed proteins. These requirements apply to control
proteins as well as the proteins of interest, thus the appro-
priate choice of controls is critically important. In practice,
these conditions can not always be met, and interpretation
of results is not always straightforward. As a consequence,Submitted November 20, 2009, and accepted for publication February 3,
2010.
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0006-3495/10/05/2391/9 $2.00significant disagreement regarding the existence of some
constitutive multiprotein complexes persists (3,5,6).
One instance where previous studies have reached
conflicting conclusions is the self-association of class A
G-protein-coupled receptors (GPCRs). Most RET studies
have concluded that these receptors form dimers or higher-
order oligomers both in reconstituted systems and living
cells (7), in agreement with earlier biochemical studies (8).
However, a few RET studies have reached the opposite
conclusion (3,9), and have criticized the methods used to
show class A GPCR self-association (3). Similarly, conflict-
ing conclusions have been drawn from RET studies of preas-
sembly of GPCRs and heterotrimeric G-proteins. It has long
been thought that the interaction between GPCRs and their
cognate G-proteins in intact cells occurs transiently, and
that productive receptor-G-protein complexes form after
receptor activation (10,11). This collision coupling model
has been challenged in large part by studies reporting con-
stitutive RET between GPCRs and G-proteins (12–15).
The model put forward to account for this observation is
that GPCRs and G-proteins are physically associated before,
during, and after receptor activation, and signaling is
mediated by structural rearrangement of stable receptor-G-
protein complexes (12). However, other studies have failed
to observe constitutive RET between GPCRs and G-proteins
(16), and no physiological role for preassembled GPCR-G-
protein complexes has yet been shown.
In this study, we describe a new method for detecting
specific constitutive association of proteins that are confined
to subcellular compartments. We validate this method using
engineered monomeric and dimeric membrane-associated
proteins, then use this method to reexamine constitutive
association of class A GPCRs with other class A GPCRs
and with heterotrimeric G-proteins.doi: 10.1016/j.bpj.2010.02.004
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Plasmid DNA constructs
A plasmid encoding Rluc8 (17) was provided by Dr. Sanjiv Sam Gambhir
(Stanford University, Palo Alto, CA). FRB and FKBP were provided by
Dr. Stephen R. Ikeda (NIAAA, Rockville, MD). Kir3.1 was provided by
Dr. Eitan Reuveny (Weizmann Institute of Science, Rehovot, Israel), and
Kir3.2 was provided by Dr. Lily Jan (UCSF, San Francisco, CA). The
a2AR was provided by Dr. Andrew Tinker (UCL, London, UK). D2R-V
was provided by Dr. Jonathan Javitch (Columbia University, New York,
NY). Various acceptor, donor and recruiter constructs contained the fol-
lowing peptide sequences:
mem (from GAP-43): MLCCLRRTKQVEKNDEDQKI;
link: GGGGSGGGGSGGGSGGELRGGELE;
zip: MNTEAARRSRARKLQRMKQLEDKVEELLSKNYHLENEVAR
LKKLVGERID; and
kras: RKHKEKMSKDGKKKKKKSKTKCVIM.
FRB-Gg2 included a GGSGG linker between the C-terminus of FRB and
the N-terminus of Gg2. The a2AR-V was made by subcloning a2AR into
mVenus-N1 with KpnI and HindIII. V-GIRK1 was made by subcloning
Kir3.1 into mVenus-C1 with BsrGI and SacI; cotransfection of V-GIRK1
and Kir3.2 produced GIRK1/2-V channels. Caveolin1-V was made by sub-
cloning rat caveolin1a into mVenus-N1 with XhoI and SacII. The construc-
tion of GaoA-V, Gb1g2-V, masGRK3ct-V, and C-TM-V have been
described previously (18,19). All constructs were verified by automated
sequencing.
Cell culture and transfection
HEK 293 cells (ATCC, Manassas, VA) were propagated in plastic flasks, in
6-well plates and on polylysine-coated glass coverslips according to the
supplier’s protocol. Cells were transfected in growth medium using linear
polyethylenimine (MW 25,000; Polysciences, Warrington, PA) at an N/P
ratio of 20; %3 mg of plasmid DNA was transfected per well of a 6-well
plate.
Guanine nucleotide depletion
For experiments such as that shown in Fig. 3 cells were resuspended in
buffer containing 140 mM potassium gluconate, 5 mMKCl, 10 mMHEPES,
1 mM EGTA, 0.3 mM CaCl2, and 1 mM MgCl2 (pH 7.2), permeabilized
with either 1000 U mL1 a-hemolysin (Sigma, St. Louis, MO; H9395) or
10 mM digitonin, and incubated with 5 mMKCN for ~15 min before making
measurements. In some experiments 0.5 mM GTPgS was added at the same
time as rapamycin.
Bioluminescence resonance energy
transfer measurements
Cells were detached from plates by rinsing with PBS-EDTA and triturating
in PBS 16–24 h after transfection. Suspended cells were transferred to black
96-well microplates. Rapamycin (5 mM; LC Laboratories, Woburn, MA)
was present in 50% of the wells, and coelenterazine h (5 mM; Nanolight
Technologies, Pinetop, AZ) was added to all wells immediately before
making measurements. Luminescence measurements were made using
a photon-counting plate reader (Mithras LB940; Berthold Technologies
GmbH, Bad Wildbad, Germany).
Confocal imaging
Confocal images (Fig. S1 in the Supporting Material) were acquired using
a Leica (Wetzlar, Germany) SP2 scanning confocal microscope and a
63, 1.4 NA objective. Venus was excited with the 514 nm line of an
ArKr laser, and detected at 520–550 nm.Biophysical Journal 98(10) 2391–2399Statistical analysis
Two different methods were used to calculate DBRETrap and to test the
hypothesis that this value was not equal to zero. In the first method the raw
bioluminescence resonance energy transfer (BRET) ratio (Em535/480) was
calculated as the number of photons counted at 535 nm divided by the num-
ber of photons counted at 480 nm for each replicate; the number of photons
counted at each wavelength was generally >105, and was always >104.
BRETbasal for each replicate was this ratio minus the Em535/480 measured
from cells expressing only the BRET donor, and DBRETrap for each
replicate was Em535/480 measured in the presence of rapamycin
minus Em535/480 in the absence of rapamycin. Values of BRETbasal and
DBRETrap reported in the text and in Tables S1–S5 in the Supporting
Material represent the mean 5 SE of replicates for a particular condition.
To test whether or not DBRETrap was significantly different from zero, a
paired t-test was carried out between within-replicate values of Em535/
480 measured in the presence of rapamycin and Em535/480 in the absence
of rapamycin for each condition. In each case the distributions of Em535/
480 passed the Shapiro-Wilk test for normality with p > 0.05. Comparisons
between conditions were made using both Student’s t-test assuming equal
variance, and the variant of this test (a.k.a. Welch’s t-test) that is insensitive
to unequal variance; p values reported in the text were derived from the
latter.
In the second method (Tables S6–S12 in the Supporting Material)
a weighted mean of photons collected at each wavelength was calculated
for each condition according to:
m
0 ¼
P
xi=s
2
i

Pð1=s2i Þ
(1)
where m0 is the weighted mean, xi is the number of photons counted for the i
th
replicate, and si is the error for the i
th replicate, defined as
ﬃﬃﬃ
xi
p
(20). This
definition assumes Poisson error in each photon count. The weighted vari-
ance ðs2mÞ of the photon counts at each wavelength was calculated as:
s2m ¼
1
Pð1=s2i Þ
(2)
The weighted mean and variance at each wavelength was then used to
calculate a weighted Em535/480 ratio 5 propagated error for each condi-
tion, and DBRETrap for each condition was calculated as the weighted
Em535/480 in the presence of rapamycin (Em535/480rap) minus the
weighted Em535/480 in the absence of rapamycin (Em535/480basal). The
propagated error in DBRETrap for each condition multiplied by the critical
value of Student’s t-distribution for the appropriate degrees of freedom
gave the 95% confidence interval; DBRETrap was considered to be signifi-
cantly different from zero if the 95% confidence interval did not encompass
zero. Agonist-induced BRET (Fig. 4 was calculated using the same
procedure).
These two methods of statistical analysis produced comparable results,
although the second method was more conservative with respect to statistical
significance. All values were rounded to two decimal places after all calcu-
lations were complete. Values reported as 0.00 were >0 and <0.005,
whereas values reported as 0.00 were >0.005 and <0.RESULTS
Validation of the third-party BRET method
We developed a general method to detect specific constitu-
tive BRET (21) between proteins located in subcellular com-
partments of living cells. This method (Fig. 1 A) relies on
rapamycin-induced dimerization of FK506 binding pro-
tein (FKBP) and the FKBP-rapamycin-binding domain of
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FIGURE 1 Third-party RET with
plasma membrane proteins. (A) Non-
specific BRET is observed between
third-party acceptors and both mono-
meric (left) and dimeric (right) donors
(top). Rapamycin-induced dimerization
of FRB and FKBP recruits acceptors
to the vicinity of dimeric donors only
(bottom). (B) Rapamycin increases
BRET only when both proteins of
interest are dimeric (n ¼ 4–8 experi-
ments, each carried out in quadru-
plicate). Symbols correspond to the
proteins indicated at the bottom and
center of A: 1, mem-l-FKBP-V þ
mem-zip-FRB þ mem-zip-Rluc8; 2,
mem-l-FKBP-V þ mem-zip-FRB þ
mem-l-Rluc8; 3, mem-l-FKBP-V þ
mem-l-FRB þ mem-zip-Rluc8; 4,
mem-l-FKBP-V þ mem-l-FRB þ
mem-l-Rluc8; 5, mem-l-FKBP-Rluc8þ
mem-zip-FRBþmem-zip-V; 6, mem-l-
FRB-V þ mem-zip-FKBP þ mem-zip-
Rluc8. (C) Rapamycin does not increase
BRET when mem-l-FKBP-Rluc8 and
mem-zip-FRB are expressed with any
of several noninteracting integral or
peripheral membrane protein acceptors
(n ¼ 5 for each). Bars represent the
mean 5 SE, and black diamonds indi-
cate data points from individual experi-
ments.
Third-Party BRET and GPCR Complexes 2393mTOR (FRB). One protein of interest is fused directly to
either the RET donor or acceptor, and the other protein of
interest (the recruiter) is fused to either FKBP or FRB. The
complementary RET acceptor or donor is fused to the
cognate FRB/FKBP moiety as well as a peptide sequence
that directs the protein to the appropriate compartment.
This protein serves as a third-party donor/acceptor. Rapamy-
cin causes FRB and FKBP to dimerize, thus recruiting the
third-party RET partner to the recruiter protein of interest.
If the two proteins of interest specifically interact, then rapa-
mycin will (under favorable conditions) induce an increase
in RET. In contrast, if the two proteins of interest do not
specifically interact then rapamycin will not change the prox-
imity of the donor and acceptor, and will not increase RET.
Any RET signal that exists before recruitment can be attrib-
uted to nonspecific collisional encounters, provided the
third-party RET partner does not interact with either protein
of interest. A critical requirement is that FKBP-FRB dimer-
ization should not change the concentration of RET donors
or acceptors within the compartment that contains the mole-
cules of interest.
To validate this method we measured basal (BRETbasal)
and rapamycin-induced (DBRETrap) BRET between engi-
neered monomeric and dimeric proteins and third-party
acceptors or donors. Proteins of interest contained a dual pal-
mitoylation sequence to direct expression at the plasma
membrane (mem), and either an inert linker peptide (l) ora leucine-zipper peptide from GCN4 (zip), which forms
stable constitutive homodimers. These were fused to the
Renilla luciferase variant Rluc8 (17) to serve as monomeric
(mem-l-Rluc8) or dimeric (mem-zip-Rluc8) BRET donors,
or to FRB to serve as monomeric (mem-l-FRB) or dimeric
(mem-zip-FRB) recruiters. The fluorescent protein venus
(V) fused to FKBP and the mem-linker peptide (mem-l-
FKBP-V) served as the third-party acceptor. When dimeric
donor and recruiter proteins were coexpressed in HEK 293
cells rapamycin induced a large increase in BRET (Fig. 1 B),
consistent with the formation of mem-zip-Rluc8/mem-zip-
FRB/mem-l-FKBP-V ternary complexes. In contrast, no
BRET increase was observed if either the donor, the recruiter
or both lacked the zip peptide. Rapamycin also increased
BRET for dimeric proteins when the positions of FKBP
and FRB were exchanged, or when the positions of Rluc8
and V were exchanged (Fig. 1 B). Importantly, all donor-
acceptor combinations produced substantial BRETbasal
(ranging from 0.05 to 0.14) before the addition of rapamycin
(Table S1 and Table S6), thus the presence of a basal BRET
signal is not a valid indicator of a constitutive protein
interaction.
The absence of a change in BRET with noninteracting
control proteins (Fig. 1 B) implies that the formation of
mem-zip-FRB/mem-l-FKBP-V complexes did not signifi-
cantly change the abundance or orientation of acceptors at
the plasma membrane, as such changes would be indicatedBiophysical Journal 98(10) 2391–2399
2394 Kuravi et al.by many different membrane-associated acceptors. We
verified this implication directly by imaging cells during
application of rapamycin. The subcellular distribution of
mem-l-FKBP-V was not detectably changed by rapamycin
in cells expressing this acceptor together with mem-zip-
Rluc8 and mem-zip-FRB (Fig. S1). The normalized ratio
of mem-l-FKBP-V intensity at the plasma membrane and
the cell interior in the presence of rapamycin was 985 1%
of the control value (n ¼ 19, p ¼ 0.16). This suggests that
rapamycin does not recruit mem-l-FKBP-V from intracel-
lular compartments to the plasma membrane, consistent
with the strong attachment of this third-party acceptor to
the plasma membrane via dual palmitoylation.
In cases where the donor and recruiter proteins specifi-
cally associate the magnitude of rapamycin-induced BRET
should depend on the relative abundance of these molecules.
Increasing the relative expression of donors should increase
the fraction of donors found in donor/donor complexes
as compared to donor/recruiter complexes. Because only
the latter can contribute to rapamycin-induced BRET,
increasing the relative expression of donors should decrease
DBRETrap. Indeed, increasing the expression of mem-zip-
Rluc8 (while keeping expression of mem-zip-FRB and
mem-link-FKBP-V constant) decreased rapamycin-induced
BRET (Fig. S2). In contrast, changing the expression of
donors and recruiters in parallel (leaving the relative
abundance of donor/donor and donor/recruiter complexes
unchanged) did not change rapamycin-induced BRET
(Fig. S2). Thus the third-party BRET method is predictably
sensitive to the donor/recruiter ratio, but is relatively insen-
sitive to the total expression level of the proteins of interest,
at least for high-affinity complexes such as those formed by
zip peptides.
To assess the ability of the third-party BRET method to
reject nonspecific interactions we expressed several integral
or peripheral plasma membrane proteins that were not
expected to specifically interact with zip peptides. Each
was fused to venus, and was coexpressed with the recruiter
mem-zip-FRB and the third-party donor mem-l-FKBP-
Rluc8. Rapamycin significantly increased BRET with the
positive control mem-zip-V, but not with any of the other
acceptor proteins (Fig. 1 C). This confirms that the BRET
increase observed with mem-zip-V was not simply due to
a change in the number or orientation of donors at the plasma
membrane. All of these acceptors generated significant
BRETbasal (Table S2 and Table S7), underscoring the pro-
pensity of membrane-associated pairs to produce nonspecific
RET (1). Interestingly, recruitment of a third-party donor or
acceptor often decreased BRET slightly when proteins of
interest were not expected to specifically interact (Fig. 1 C).
The mechanism of this decrease is not clear, although one
plausible explanation is that the rapamycin-induced interac-
tion between the recruiter and the third-party partner steri-
cally occludes a fraction of the random encounters that
produce nonspecific RET.Biophysical Journal 98(10) 2391–2399Self-association of class A GPCRs
Previous Fo¨rster resonance energy transfer and BRET
studies have made extensive use of saturation methods to
determine the specificity of class A GPCR self-association.
As the third-party BRET method is conceptually distinct
from saturation methods, we used this method to reexamine
the self-association of b2 adrenoreceptors (b2ARs; Fig. 2 A).
This receptor was the subject of one of the first reports of
class A GPCR dimerization (8), but has also been the subject
of conflicting saturation BRET studies (3,6,22). When
b2AR-Rluc8 and b2AR-FRB were expressed together with
mem-l-FKBP-V, rapamycin reliably induced a significant
increase in BRET (Fig. 2 B), consistent with the self-associ-
ation of b2ARs. No such increase was observed with b2AR-
FRB and several other membrane-associated donors, even
though substantial BRETbasal was observed with all of these
donors (Table S3 and Table S8). A smaller but still highly
significant BRET increase was observed when b2AR-V and
b2AR-FRB were expressed together with mem-l-FKBP-
Rluc8 (DBRETrap ¼ 0.01 5 0.00; p < 0.0001; n ¼ 10).
Coexpression of increasing amounts of unlabeled b2AR pro-
gressively decreased the magnitude of rapamycin-induced
BRET between b2AR-Rluc8 and mem-l-FKBP-V (with
b2AR-FRB; Fig. S3), consistent with genuine self-associa-
tion of b2ARs. Finally, acute activation of b2AR-Rluc8
and b2AR-FRB with 10 mM isoproterenol had no effect on
DBRETrap (0.04 5 0.00 and 0.04 5 0.00, control and
isoproterenol, respectively; p ¼ 0.94; n ¼ 5).
Several class A GPCRs are thought to associate with
b2ARs, including other adrenoreceptors (23,24). Therefore,
we examined the association of b2AR-FRB with several
other class A GPCR donors. These receptors supported
varying levels of BRETbasal before addition of rapamycin
(Table S4 and Table S9). Several of these receptors also sup-
ported rapamycin-induced BRET, suggesting that they asso-
ciated with b2AR-FRB (Fig. 2 C). None of the other GPCR
donors studied produced DBRETrap that approached the
magnitude of that produced by b2AR-Rluc8, suggesting
that b2ARs may prefer homomeric interactions over hetero-
meric interactions. Interestingly, DBRETrap was strongly
negative when either M3 or M4 muscarinic acetylcholine
receptors was used as the BRET donor (p ¼ 0.047 and
0.014, respectively). This result suggests that these receptors
may be less likely than other class A GPCRs to associate
with b2ARs.
Preassembly of GPCRs and G-proteins
We then used this method to reexamine constitutive interac-
tions between GPCRs and heterotrimeric G-proteins (12,13)
(Fig. 3 A). FRB was fused to the amino terminus of the Gg2
subunit to serve as a recruiter, and this was paired with the
third-party donor mem-l-FKBP-Rluc8. Gg and Gb subunits
form obligate dimers, therefore Gb1 was expressed with
FRB-Gg2 to allow formation of FRB-Gb1g2 dimers.
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mem-l-FKBP-VB
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FIGURE 2 b2 adrenoreceptors self-associate and associate with other
class A GPCRs. (A) Schematic illustrating the use of third-party BRET to
detect b2AR self-association. (B) Rapamycin significantly increases
BRET with b2AR-Rluc8 as the donor and b2AR-FRB as the recruiter
(n ¼ 5), but not several other membrane-associated donors (n ¼ 4–5); in
all cases mem-l-FKBP-V was the third-party acceptor. (C) Heteromeric
association of the recruiter b2AR-FRB with various class A GPCRs as
donors and mem-l-FKBP-V as the third-party acceptor. In addition to
b2AR-Rluc8 (n ¼ 10), donor GPCRs (n ¼ 5 for each) included a2 adrenor-
eceptors (a2AR-Rluc8), D2 and D1 dopamine receptors (D2R-Rluc8 and
D1R-Rluc8), M3 and M4 muscarinic acetylcholine receptors (M3R-Rluc8
and M4R-Rluc8), m opioid receptors (MOR-Rluc8), and CB1 cannabinoid
receptors (CB1R-Rluc8). Bars represent the mean 5 SE, and black dia-
monds indicate data points from individual experiments.
Third-Party BRET and GPCR Complexes 2395Rapamycin increased BRET when these proteins were
expressed with GaoA-V (DBRETrap ¼ 0.055 0.00; n ¼ 4;
p < 0.005; Fig. 3 B), demonstrating that FRB-Gb1g2
could form heterotrimers and recruit mem-l-FKBP-Rluc8.Rapamycin also significantly increased BRET when FRB-
Gb1g2 was expressed with a membrane-associated fragment
of G-protein receptor kinase 3 (masGRKct-V) or G-protein-
regulated inwardly-rectifying potassium channels (GIRK1/
2-V; Fig. 3 B), both of which are known to form transient
(lifetime < 1 s) complexes with Gbg dimers. Thus FRB-
Gb1g2 dimers were capable of reporting association with
several Gbg-interacting proteins. In contrast, rapamycin
decreased BRET when FRB-Gb1g2 was expressed with
unlabeled Gai1 and a venus-labeled a2A-adrenoreceptor
(a2AR-V). Similarly, rapamycin decreased BRET when
either of two negative control acceptor proteins was
expressed (Fig. 3 B). All of these acceptor proteins produced
significant BRETbasal with mem-l-FKBP-Rluc8 (Table S5
and Table S10).
Previous studies concluded that inactive a2ARs and
G-proteins form preassembled complexes, in part because
basal RET was observed between a2ARs and heterotrimers
(12,13). Because we did not detect a constitutive interaction
between FRB-Gb1g2 and a2AR-V, we wanted to confirm
that FRB-Gb1g2 formed heterotrimers with Gai1 that could
interact with a2AR-V. Activation of a2AR-V receptors
with the agonist UK 14,304 converted the rapamycin-
induced BRET decrease into a small increase (Fig. 3 C).
This finding is consistent with previous reports of agonist-
induced RET increases between a2ARs and Gbg dimers
(12,16). The ternary complex model of GPCR signaling
predicts that active-state agonist-receptor-G-protein com-
plexes will be particularly stable when G-proteins lack
access to guanine nucleotides (11,25). Accordingly, when
permeabilized cells were depleted of nucleotides the rapamy-
cin-induced BRET decrease was converted into a large
increase, but only when agonist was present (Fig. 3 C).
Nucleotide depletion alone (in the absence of agonist) did
not affect the rapamycin-induced BRET decrease. The
combined effect of agonist and nucleotide depletion was pre-
vented by the poorly-hydrolyzable analog GTPgS. These
results are thus consistent with the ternary complex model,
and demonstrate that FRB-Gb1g2 and Gai1 formed hetero-
trimers that interacted with a2AR-V in an agonist-dependent
manner. These results were not dependent on a particular
configuration of donor, recruiter and acceptor, as similar
results were obtained with a2AR-Rluc8 as the donor or
with a2AR-FRB as the recruiter (Fig. 3 C).
We also asked if this pattern of BRET changes was unique
to a2 adrenoreceptors. Experiments using the same G-
protein recruiter (Gai1 þ FRB-Gb1g2) and third-party
acceptor (mem-l-FKBP-V) were carried out with three addi-
tional Gai/o-coupled GPCRs as donors: dopamine D2 recep-
tors (D2R-Rluc8), M4 muscarinic acetylcholine receptors
(M4R-Rluc8), and CB1 cannabinoid receptors (CB1R-
Rluc8). Results obtained with D2R-Rluc8 and M4R-Rluc8
were similar to those obtained with a2AR-Rluc8 (Fig. 3 D
and Table S11), in that rapamycin decreased BRET in unsti-
mulated cells, stimulation with agonist lessened this decreaseBiophysical Journal 98(10) 2391–2399
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A B FIGURE 3 Class A GPCRs do not
preassemble with G-protein hetero-
trimers. (A) Schematic illustrating the
use of third-party BRET to detect asso-
ciation of G-proteins with GPCRs.
(B) Interactions between FRB-Gb1g2
dimers and a Ga subunit, effectors and
a2AR-V; in all experiments mem-l-
FKBP-Rluc8 was the third-party donor.
Rapamycin significantly increases
BRET between FRB-Gb1g2 (FRB-
Gg2 þ Gb1) and GaoA-V, and the
Gbg-binding proteins masGRKct-V
and GIRK1/2-V, but not the control
proteins mem-zip-V or V-kras (n ¼ 4).
Rapamycin also did not increase
BRET between FRB-Gb1g2 and the
a2AR-V receptor in the presence of
Gai1. (C) The a2AR-V agonist UK
14,304 (10 mM) converted the rapamy-
cin-induced BRET decrease into a small
increase in intact cells, and a highly-
significant increase in guanine nucleo-
tide (GXP)-depleted (permeabilized)
cells (n ¼ 4). This change was abol-
ished by 0.5 mM GTPgS. (D) Experi-
ments analogous to A with D2
dopamine receptors (D2R-Rluc8; left;
n ¼ 3), M4 muscarinic acetylcholine
receptors (M4R-Rluc8; middle; n ¼ 3)
and CB1 cannabinoid receptors (CB1R-
Rluc8; right; n¼3). Agonists were quin-
pirole (10 mM), carbachol (100 mM) and
WIN 55,212 (1 mM); *p < 0.05; **p <
0.005, unpaired t-test. Bars represent
the mean 5 SE, and black diamonds
indicate data points from individual
experiments.
2396 Kuravi et al.or induced a slight increase, and the effect of agonist was
enhanced in nucleotide-depleted cells. In contrast, rapamycin
produced a small but significant increase in BRET in unsti-
mulated cells expressing CB1R-Rluc8 (DBRETrap¼ 0.015
0.00; p < 0.0005; n ¼ 4), suggesting that some of these
receptors were associated with G-proteins containing FRB-
Gb1g2 in the absence of an agonist. The specific CB1R
agonist WIN 55,212 significantly enhanced the rapamycin-
induced BRET increase (Fig. 3 D). These findings are
consistent with the known properties of CB1 receptors,
which exhibit a high degree of constitutive activity that
can be enhanced further by a full agonist (26). If constitutive
activity was responsible for association of unliganded
CB1R-Rluc8 and G-proteins, then nucleotide depletion
alone would be expected to enhance this association. Indeed,
in contrast to the other GPCRs we studied, nucleotide deple-
tion alone enhanced the rapamycin-induced BRET signal
generated by CB1R-Rluc8 (Fig. 3 D). Furthermore, rapamy-
cin failed to significantly increase BRET in cells expressing
CB1R-Rluc8 in the presence of the inverse agonist SRBiophysical Journal 98(10) 2391–2399141716A (DBRETrap ¼ 0.00 5 0.00; p ¼ 0.37; n ¼ 4).
Taken together, these results show that the third-party
BRET method detects active-state complexes but not preas-
sembled inactive-state complexes between several GPCRs
and G-proteins.
Finally, the possibility remained that inactive GPCRs and
G-proteins formed preassembled inactive-state complexes
that did not permit rapamycin-induced BRET, and that
agonist activation produced a conformational change that
permitted rapamycin-induced BRET. We tested this possi-
bility by introducing a second GPCR to compete for
G-proteins. If the agonist-induced increase in BRET in the
presence of rapamycin reflected a conformational change
of a stable GPCR-Rluc8/G-protein complex, then activation
of a second (unlabeled) GPCR should be unable to influence
this change. Alternatively, if the agonist-induced increase in
BRET in the presence of rapamycin reflected association of
GPCR-Rluc8 and G-protein, then activation of a second
GPCR should be able to compete for G-proteins and
thus inhibit the increase. To test this idea we expressed
FRB-Gβ1γ2 + Gαi1 + m-l-FKBP-V + rapamycin
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FIGURE 4 Competition for G-proteins between labeled and unlabeled
GPCRs. (A) Agonist induced BRET between a2AR-Rluc8 and Gai1b1g2-
FRB:mem-l-FKBP-V complexes was significantly reduced by coactivation
of unlabeled M4Rs (þCch, 100 mM carbachol; n ¼ 8). Conversely, agonist
induced BRET between M4R-Rluc8 and Gai1b1g2-FRB-mem-l-FKBP-V
complexes was reduced significantly by coactivation of unlabeled a2ARs
(þUK, 10 mM UK 14,304; n ¼ 8). Rapamycin (5 mM) was present
throughout. Bars represent the mean 5 SE, and black diamonds indicate
data points from individual experiments. ***p < 0.0005, unpaired t-test.
(B) Activation of unlabeled a2ARs with UK 14,304 (10 mM) rapidly
decreases acetylcholine (Ach; 100 mM)-induced BRET between M4R-
Rluc8 and Gai1b1g2-V (n ¼ 24).
Third-Party BRET and GPCR Complexes 2397a2AR-Rluc8, FRB-Gb1g2, and Gai1 together with unlabeled
M4R and the third-party acceptor mem-l-FKBP-V. In the
continuous presence of rapamycin, the a2AR agonist UK
14,304 induced an increase in BRET, which was reduced
significantly when M4Rs were activated with carbachol
(100 mM; p < 0.0005; Fig. 4 A and Table S12). We alsocarried out the converse experiment with M4R-Rluc8 and
unlabeled a2ARs with similar results (p < 0.0005; Fig. 4 A).
Competition between GPCRs for freely-exchanging
G-proteins should occur with a rapid time course. To test
this idea, we carried out a similar experiment to that shown
in Fig. 4 A, and monitored BRET between M4R-Rluc8 and
Gai1b1g2-V during application of acetylcholine and the
subsequent addition of UK 14,304. As shown in Fig. 4 B,
activation of unlabeled a2ARs decreased agonist-induced
BRET between M4R-Rluc8 and Gai1b1g2-V within a few
seconds. These results are difficult to reconcile with the
idea that either receptor is permanently associated with
G-protein heterotrimers, and imply that the agonist-induced
signal reflects an association event rather than a conforma-
tional change within a preassembled inactive-state complex.DISCUSSION
The widespread use of RET techniques to study protein-
protein interactions has led to the refinement of several
experimental methods to distinguish signals that arise from
specific interactions from those that arise from random inter-
actions (4). The techniques used most commonly measure
changes in energy transfer that occur as the ratio of acceptors
to donors or the total concentration of acceptors and donors
increases, and compare these changes to predictions made by
simplified models (2,27,28). Although these methods have
proven to be extremely useful, they are not without limita-
tions. For example, specific interactions produce RET that
saturates as the abundance of acceptors increases. However,
nonspecific interactions also produce RET that is saturable or
quasi-linear as acceptor density increases (3,4). No widely
accepted criteria exist for objectively distinguishing the
two situations. A potential remedy for this problem is to
compare proteins of interest to several control proteins that
have similar characteristics, but here too criteria defining
what constitutes an appropriate control are not applied
uniformly.
We developed a new method for distinguishing nonspe-
cific and specific constitutive interactions using RET. The
third-party approach is unrelated to existing methods, thus
it avoids many of the problems associated with these
methods. Third-party RET is conceptually straightforward,
and does not require graded expression or quantitation of
acceptors or donors. This method does require construction
of third-party donors or acceptors, as well as control experi-
ments to ensure that donor or acceptor concentration or
orientation do not change. Although in this study we
restricted our attention to signaling proteins located at the
plasma membrane, by directing third-party RET partners to
other subcellular compartments it should be possible to use
this method to gain information regarding interactions in
these compartments. Finally, although our studies used
BRET, this approach is equally applicable to other RET
techniques.Biophysical Journal 98(10) 2391–2399
2398 Kuravi et al.The third-party method also has important limitations.
The failure to observe a signal with a given pair of proteins
does not by itself rule out the existence of a specific interac-
tion. This limitation is shared by all RET methods, but
energy transfer involving a third-party is necessarily more
complex than direct transfer between proteins of interest,
therefore this problem is likely to be worse with third-party
RET than with other methods. Similarly, like other RET
methods our approach can not distinguish direct protein-
protein interactions from indirect interactions that bring
proteins of interest into close proximity. Finally, net energy
transfer involving a third-party will depend on many factors,
including the stoichiometry of the proteins involved and the
conformation of the rapamycin-induced ternary complex.
Therefore, the absolute magnitude of DBRETrap can not be
used to draw quantitative inferences regarding the stability
or structure of protein complexes. Because of these limita-
tions, third-party RET will, like other methods, be most
useful when used in conjunction with other methods to
discriminate and characterize specific and nonspecific inter-
actions (e.g., Fig. S3).
In this study, we used third-party BRET to reexamine two
questions related to interactions between GPCR signaling
molecules about which previous studies have disagreed.
Most previous RET studies have concluded that class A
GPCRs self-associate as dimers or higher-order oligomers.
Recently, however, James et al. (3) reexamined this question
with a variant of the saturation methods used by others. They
concluded that class A GPCRs do not self-associate, and that
prior studies either misinterpreted or incorrectly applied the
theory underlying this type of experiment (3,6). The third-
party BRET method described here does not rely on the theo-
retical changes in RET efficiency that underlie saturation
methods. Our results support the conclusion that b2 adrenor-
eceptors self-associate in living cells, in agreement with
previous saturation RET studies in cells (22,29) and phos-
pholipid vesicles (30), as well as previous biochemical stud-
ies (8). Therefore, the experimental framework proposed by
James et al. (3) does not seem to be a significant improve-
ment over other methods based on systematic changes in
acceptor and/or donor density. Our results also suggest that
b2 adrenoreceptors associate with several other class A
GPCRs, including some that have not been reported previ-
ously to interact with these receptors. The third-party RET
method may thus prove useful for studies designed to detect
and monitor GPCR association in intact cells.
We also examined the association of GPCRs and heterotri-
meric G-proteins before and during receptor activation.
The ternary complex model described by De Lean et al.
(11) includes a substantial fraction of precoupled receptor-
G-protein complexes that form spontaneously (without
agonist occupancy of the receptor). This precoupled popula-
tion of receptors corresponds to the fraction of high affinity
agonist binding sites in membrane preparations. Such pre-
coupled complexes do not accumulate when guanine nucle-Biophysical Journal 98(10) 2391–2399otides are present, as indicated by the lack of high affinity
agonist binding in intact cells (31,32). However, this obser-
vation does not rule out the possibility that receptors and
G-proteins may be preassembled in structurally distinct inac-
tive-state complexes or colocalized in domains. Several
recent studies using conventional RET methods have pro-
vided evidence for such preassembled complexes in intact
cells (12–15) but see Hein (16) and Azpiazu and Gautam
(33). The purported advantages of such an arrangement
include facilitation of rapid and specific signaling.
In this study, third-party BRET failed to detect inactive-
state complexes containing GPCRs and G-proteins.
As pointed out above, by itself this failure is not strong evi-
dence that such complexes do not exist. However, we could
detect active-state complexes with third-party BRET using
three different recruiter-third-party combinations and with
several different GPCRs, suggesting the assay is robust with
respect to known ternary complexes. Moreover, we show
that the BRET signal that appears with receptor activation
results from an association event, rather than a conforma-
tional change. Therefore, we conclude that it is unlikely
that the receptors we studied form stable preassembled
complexes with heterotrimeric G-proteins. Specifically, our
results suggest that the receptors we studied do not directly
associate with their cognate G-proteins in stable inactive-
state complexes. Our results do not speak to the possibility
that natively-expressed GPCRs and G-proteins may bind to
a common scaffold or be concentrated in a common domain
in other cell types. Nevertheless, several studies have shown
rapid and specific signaling using the same cells and recep-
tors used in this study (12,16,34). Therefore, a collision
coupling mechanism seems to be sufficient to support rapid
and specific signaling by GPCRs.SUPPORTING MATERIAL
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